- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05960734
Artificial Intelligence in Healthcare: Advanced Evaluation of Medical Online Content. AI-driven Quality Assessment of YouTube Videos Providing Information on Incontinence After Cancer Surgery. (AMRR UOPhD)
December 12, 2024 updated by: Alvaro Manuel Rodriguez Rodriguez, University of Oviedo
Artificial Intelligence in Healthcare: Advanced Evaluation of Medical Online Content. Assessment of Health Knowledge and Related Educational Intervention.
The aim of the study is to analyse the quality of information that patients and relatives of different types of cancer receive through social networks on the subject of incontinence after cancer surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
The primary goal of this study is to meticulously analyze and evaluate the overall quality of information that patients and their relatives obtain through social networks.
The specific focus of the investigation lies in exploring the subject of incontinence after cancer surgery, encompassing a diverse range of cancer types.
By closely examining the information disseminated across various social platforms, the researchers aim to shed light on the accuracy, reliability, and comprehensiveness of the information available.
Ultimately, this study seeks to enhance our understanding of the information landscape surrounding post-cancer surgery incontinence, empowering patients and their relatives to make well-informed decisions regarding their healthcare.
Study Type
Observational
Enrollment (Actual)
160
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Asturias
-
Oviedo, Asturias, Spain, 33006
- University of Oviedo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
160 samples providing information about incontinence after cancer surgery.
Description
Inclusion Criteria:
- Anyone providing information about incontinence after cancer surgery.
- English language
Exclusion Criteria:
- Non-english language
- Duplicated
- Related with advertisements
- Nonrelated to incontinence
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Samples group
Samples collected regarding the online information about incontinence after cancer surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analisys of the information in social networks about incontinence after cancer surgery
Time Frame: 2023-2024
|
Analisys of the information in social networks about incontinence after cancer surgery
|
2023-2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Maria Blanco-Diaz, Prof. PhD., University of Oviedo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2023
Primary Completion (Actual)
August 1, 2023
Study Completion (Actual)
November 1, 2023
Study Registration Dates
First Submitted
July 17, 2023
First Submitted That Met QC Criteria
July 17, 2023
First Posted (Actual)
July 27, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 12, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- AMRR UOPhD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The individual participant data will be shared once the study has been completed in its entirety and always respecting the requirements of the Personal Data Protection Law.
IPD Sharing Time Frame
2024-2025
IPD Sharing Access Criteria
Via email with the Principal Researcher.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting